Keywords: pain, compound, deal, enhance, alza, biotech, developer

Pain compound deal for Enhance and Alza

Article | 08 November 2004

Print This

Enhance Biotech, a developer of a portfolio of products focused on lifestyle drugs, says that its new merger partner Ardent ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in